（一）增资基本情况 证券代码：600129 证券简称：太极集团 公告编号：2026-003 重庆太极实业（集团）股份有限公司 关于对全资子公司增资的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示： ●本次增资公司名称：运城市太极数智中药有限公司（以下简称 "运城数智中药"）。 ●增资金额及资金来源：重庆太极实业（集团）股份有限公司（以 下简称"公司"或"太极集团"）拟以自有资金对运城数智中药增资 4,670万元人民币。 ●本次对运城数智中药增资事宜经公司第十届董事会第三十五 次会议审议通过。根据《上海证券交易所股票上市规则》及《公司章 程》等相关规定，该事项无需提交股东会审议。 ●本次增资事宜不构成《上海证券交易所股票上市规则》和《公 司章程》规定的关联交易，也不构成《上市公司重大资产重组管理办 法》规定的重大资产重组情形。 一、本次增资概述 运城数智中药为公司全资子公司，为满足其业务发展需要，公司 拟以自有资金4,670万元对其增资，增资后运城数智中药注册资本由 30万元变更为4,700万元，仍为公司全 ...

证券代码：600129 证券简称：太极集团 公告编号：2026-001 重庆太极实业（集团）股份有限公司 第十届董事会第三十五次会议决议公告 1 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重庆太极实业（集团）股份有限公司（以下简称：公司）第十届 董事会第三十五次会议于 2026 年 1 月 9 日以邮件方式发出书面通知， 于 2026 年 1 月 21 日以现场及视频方式召开。本次会议由董事长俞敏 先生主持，会议应到董事 13 人，实到董事 13 人，公司高级管理人员 列席了会议。本次会议的召集、召开程序符合《公司法》和《公司章 程》的有关规定，会议合法有效。会议审议并通过了如下议案： 一、关于预计公司 2026 年度日常关联交易额度的议案（具体内 容详见公司披露的《关于预计公司 2026 年度日常关联交易额度的公 告》；公告编号：2026-002） 2026 年公司拟向关联人采购商品和接受劳务 42,900 万元，向关 联人销售商品和提供劳务 80,150 万元；在关联人的财务公司日存款 余额不超过 50,000 万 ...

格隆汇1月22日丨太极集团(600129.SH)公布，运城数智中药为公司全资子公司，为满足其业务发展需 要，公司拟以自有资金4670万元对其增资，增资后运城数智中药注册资本由30万元变更为4700万元，仍 为公司全资子公司。 中药材资源板块是公司战略规划重要组成部分，公司对运城数智中药增资，主要为补充其流动资金，有 利于优化资产负债结构、提升资本实力及抗风险能力，保障中药材稳定供应，强化对外市场拓展与核心 产品品牌培育，进一步提升公司在中药材领域的整体竞争力。 ...

每经头条（nbdtoutiao）——特朗普强要格陵兰岛，丹麦一养老基金率先清仓美债，美国资产全线下 跌！欧洲手握"金融核按钮"，双方会"鱼死网破"吗？专家解读→ （记者 王晓波） 每经AI快讯，太极集团1月22日晚间发布公告称，公司第十届第三十五次董事会会议于2026年1月21日 以现场及视频方式召开。会议审议了《关于预计公司2026年度日常关联交易额度的议案》等文件。 ...

Core Viewpoint - The collaboration between Zhejiang and Fuling has evolved over 33 years, transitioning from basic support to a comprehensive partnership that enhances industrial development and improves living standards in Fuling, showcasing a successful model of east-west cooperation in China [1][6]. Group 1: Historical Context and Development - The partnership began in 1992 with the signing of the first support agreement, aimed at aiding the Three Gorges Reservoir area, marking the start of a long-term collaboration [1]. - Over the years, Fuling has transformed from an agricultural area to an industrial hub, driven by national strategies such as the Western Development and the Chengdu-Chongqing Economic Circle [1]. Group 2: Business Environment and Investment - Fuling has made significant efforts to improve its business environment, adopting a service-oriented approach to attract and retain enterprises, exemplified by the case of Huafeng Group, which established operations in Fuling after extensive engagement [2][3]. - The region has attracted over 1,000 Zhejiang merchants and more than 290 Zhejiang enterprises, with cumulative investments exceeding 50 billion yuan, contributing to about 25% of the district's industrial output [5]. Group 3: Talent and Knowledge Exchange - The collaboration has facilitated the exchange of over 390 young cadres from Fuling to Zhejiang for training, fostering a transfer of development methodologies and governance practices [4]. - Companies like Huafeng Group have brought innovative practices and cluster development strategies to Fuling, leading to the establishment of significant production bases in the region [4]. Group 4: Social and Economic Impact - Zhejiang's support has included over 5.09 billion yuan in aid for various social projects, significantly improving living conditions in Fuling [6][7]. - Initiatives such as environmental upgrades in local communities and agricultural development have resulted in increased incomes for residents, with some households seeing annual income increases of over 6,000 yuan [7]. Group 5: Future Prospects - The partnership is set to accelerate further, with 16 new investment projects from Zhejiang planned, focusing on cutting-edge sectors like new energy and electronic information, with a total investment agreement nearing 10 billion yuan [5].

Market Overview - The Chinese medicine sector experienced a decline of 0.32% on December 30, with *ST Changyao leading the drop [1] - The Shanghai Composite Index closed at 3965.12, down 0.0%, while the Shenzhen Component Index closed at 13604.07, up 0.49% [1] Stock Performance - Notable gainers in the Chinese medicine sector included: - Taiji Group (600129) with a closing price of 18.25, up 2.07% [1] - Wanbangde (002082) at 13.89, up 1.98% [1] - Fangsheng Pharmaceutical (603998) at 11.29, up 1.62% [1] - Conversely, *ST Changyao (300391) saw a significant drop of 19.49%, closing at 0.95 [2] Trading Volume and Value - The trading volume and value for key stocks were as follows: - Taiji Group: 87,200 shares traded, with a transaction value of 159 million [1] - Wanbangde: 164,400 shares traded, with a transaction value of 227 million [1] - Fangsheng Pharmaceutical: 48,000 shares traded, with a transaction value of 53.82 million [1] Capital Flow - The Chinese medicine sector experienced a net outflow of 231 million from institutional investors, while retail investors saw a net inflow of 280 million [2] - The capital flow for specific stocks included: - Wanbangde with a net inflow of 48.79 million from institutional investors [3] - Taiji Group with a net inflow of 18.53 million from institutional investors [3] - *ST Changyao had a net outflow of 19.49% [2]

Core Viewpoint - The company has changed its official email address for communication with investors, effective immediately from the date of the announcement [1]. Group 1: Email Change Details - The previous email address was tjzq@taiji.com, and the new email address is tjzq@sinopharm.com [1]. - Other contact information, such as office address and phone number, remains unchanged [1]. - The company requests investors to take note of the new email address and apologizes for any inconvenience caused [1].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重庆太极实业（集团）股份有限公司（以下简称：公司）根据实 际工作需要，对公司电子邮箱进行变更，具体情况如下： 变更前的公司电子邮箱：tjzq@taiji.com 证券代码：600129 证券简称：太极集团 公告编号：2025-093 重庆太极实业（集团）股份有限公司 关于变更公司电子邮箱的公告 除上述变更外，公司办公地址、联系电话等其他联系方式保持不 变。变更后的电子邮箱自本公告披露之日起正式启用，原邮箱地址同 步停用，敬请广大投资者注意。由此给投资者带来的不便，敬请谅解。 欢迎广大投资者通过新的电子邮箱与公司沟通交流。 变更后的公司电子邮箱：tjzq@sinopharm.com 重庆太极实业（集团）股份有限公司 2025 年 12 月 30 日 ...

Group 1 - The core point of the announcement is that Taiji Group's shareholder, Chongqing Taiji Medicinal Plant Resources Development Co., Ltd., plans to absorb and merge its wholly-owned subsidiary, Chongqing Fuling Xilan Biotechnology Co., Ltd., with no impact on the company's control and operational independence [1][2] - The merger involves the transfer of shares: Xilan Biotechnology currently holds 11.8953 million unrestricted circulating shares, accounting for 2.157% of the total share capital of Taiji Group, which will be fully inherited by the resources company after the merger [1] - Post-merger, the resources company's shareholding in Taiji Group will increase from 367,300 shares to 12.2626 million shares, raising its ownership percentage from 0.067% to 2.224% [1] Group 2 - The merger does not involve any changes in equity increase or decrease, and the controlling shareholder, Taiji Group Co., Ltd., along with its concerted parties, will maintain a total shareholding of 1.661 billion shares, representing 30.118% [1] - The announcement clarifies that the transaction will not affect the personnel, assets, finances, business, or institutional independence of Taiji Group, and there are no circumstances that would harm the interests of the company and all shareholders [1] - Both the resources company and Xilan Biotechnology are wholly-owned subsidiaries within the Taiji Group system, with the former focusing on traditional Chinese medicine cultivation and research, while the latter is dedicated to the development and research of biopharmaceutical products [2]

Group 1 - Zhuolang Intelligent's subsidiary plans to increase capital by 900 million yuan to its wholly-owned subsidiary in Xinjiang [1] - Zhenhua Heavy Industry signed a contract worth 1.149 billion yuan with Guangzhou Salvage Bureau for a deep-water crane ship construction project [2] - Ugreen Technology intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its global strategy [3] Group 2 - Guangsheng Nonferrous Metals will change its stock name to Zhongxi Rare Metals starting December 31, 2025 [4] - China Electric Research proposed a cash dividend of 2.5 yuan per 10 shares for the first three quarters of 2025 [5] - Chaoyan Co. is establishing a fund with professional investment institutions, aiming to raise 1 billion yuan [6] Group 3 - Silk Road Vision's subsidiary plans to sell 8.5% of Ruijun Technology for 52.7 million yuan [7] - Longgao Co.'s actual controller is transferring 4.37% of the investment development group's equity for 398 million yuan [8] - Weiteou signed a strategic cooperation agreement with Huaruixin Energy to develop new materials and applications [9][10] Group 4 - Annuoqi decided to terminate the investment in a 50,000-ton dye intermediate project due to market changes, with a total investment of 421 million yuan [12] - Akoli's subsidiary has entered trial production for a project with an annual capacity of 20,000 tons of polyether amine [13] - Ningbo Construction's subsidiary signed a construction contract worth 451 million yuan for a comprehensive utility tunnel project [14] Group 5 - Zhejiang Rongtai and Weichuang Electric plan to establish a joint venture in Thailand for R&D and production of mechatronic components [15] - Jiuzhoutong's subsidiary received a drug registration certificate for isopropazine injection [16] - Huaqin Technology's subsidiary signed a daily operation contract worth 392 million yuan [17] Group 6 - ST Meichen completed the sale of 100% equity in Hainan Meichen Ecological Development Co., Ltd. [18] - Pulite's LCP film products have begun mass production for a leading customer in the consumer electronics industry [19][20] - Nanjing Public Utility's major shareholder transferred 7.61% of the company's shares for 300 million yuan [21] Group 7 - Solar Energy terminated the investment in a 150 MW distributed photovoltaic project due to increased investment risks [22] - Yuntian Lifa won a 122 million yuan project for AI development in Longgang [23] - Changchun High-tech's subsidiary received acceptance for a clinical trial application for GenSci141 ointment [24] Group 8 - Changfei Optical Fiber's major shareholder completed a share reduction plan, selling 1.1 million shares for approximately 104.5 million yuan [25] - Sandam Membrane plans to apply for a comprehensive credit limit of up to 100 million yuan for 2026 [26] - Aisecurity received a government subsidy of 3.4611 million yuan [27] Group 9 - Stone Technology's H-share issuance has received approval from the China Securities Regulatory Commission [28] - Hongxing Development's subsidiary plans to suspend production to comply with national hazardous chemical relocation policies [29] - Guodian Nanzi's vice president and chief engineer resigned [30] Group 10 - Jianghe Group's subsidiary won a bid for a city renovation project in Haikou worth approximately 112 million yuan [31] - Gaotie Electric's subsidiary won a bid for a railway project worth 59.0317 million yuan [32] - Huicheng Co. plans to introduce a new partner to its major shareholder [33] Group 11 - Pumen Technology's folic acid testing kit received a medical device registration certificate [34] - Hai Xin Co.'s vitamin B6 injection passed the consistency evaluation for generic drugs [35] - Taiji Group's shareholder plans to merge with its subsidiary [36] Group 12 - Shengyi Electronics adjusted the maximum repurchase price to no more than 144.36 yuan per share [37]